跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 345 条关于
“KLARITY”
全部
345
临床试验
268
药物
5
机构
11
资讯
61
去年
Kiora Pharmaceuticals Advances Retinal Disease Pipeline with Positive Q3 Results
9个月前
Kiora Pharmaceuticals Secures New Patent for KIO-104 Formulations, Extending Market Protection to 2043
去年
Kiora Pharmaceuticals Advances Two Phase 2 Retinal Disease Trials, Secures $110M Asian Partnership
去年
Kiora Pharmaceuticals Advances KIO-104 to Phase 2 Trial for Retinal Macular Edema Treatment
去年
Clarity Pharmaceuticals Initiates Phase I/IIa Trial of 64Cu-SAR-bisPSMA for Metastatic Castration-Resistant Prostate Cancer
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA Gain FDA Fast Track Designations for Prostate Cancer
去年
Sarepta's Elevidys Data Leaves Duchenne Community Seeking More Clarity
去年
Clarity Pharma Shares Surge on Production Deal with Nucleus Radiopharma for Prostate Cancer Drug
去年
Clarity Pharmaceuticals and Nucleus RadioPharma Partner to Scale Up Production of 67Cu-SAR-bisPSMA for Prostate Cancer Treatment
去年
FDA Fast-Tracks Clarity Pharmaceuticals' Novel Prostate Cancer Imaging Agent
第 1 页,共 7 页
上一页
下一页